BioPharma Credit PLC Notice of Full Year Results (2017D)
17 February 2020 - 9:10PM
UK Regulatory
TIDMBPCR
RNS Number : 2017D
BioPharma Credit PLC
17 February 2020
17 February 2020
BIOPHARMA CREDIT PLC
(the "Company")
NOTICE OF FULL YEAR RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences
debt investor, will announce its audited Full Year Results for the
period ending 31 December 2019 on Tuesday 10 March 2020.
A management presentation will be delivered at 2:00pm GMT
through a conference call facility, to request conference call
details, RSVP to henryw@buchanan.uk.com .
-Ends-
Enquiries
BioPharma Credit PLC
via Link Company Matters Limited
Company Secretary
+44 (0) 1392 477 500
Buchanan
+44 (0)20 7466 5000
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORGPURUPUPUGUM
(END) Dow Jones Newswires
February 17, 2020 05:10 ET (10:10 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2023 to Apr 2024
